136.44
3.81 (2.87%)
| Penutupan Terdahulu | 132.63 |
| Buka | 133.97 |
| Jumlah Dagangan | 767,021 |
| Purata Dagangan (3B) | 671,691 |
| Modal Pasaran | 7,680,309,760 |
| Harga / Pendapatan (P/E TTM) | 13,644.00 |
| Harga / Pendapatan (P/E Ke hadapan) | 70.92 |
| Harga / Jualan (P/S) | 10.52 |
| Harga / Buku (P/B) | 3.58 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 24 Feb 2026 |
| Margin Keuntungan | -3.53% |
| Margin Operasi (TTM) | 5.59% |
| EPS Cair (TTM) | -0.420 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 10.40% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 76.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 34.44% |
| Nisbah Semasa (MRQ) | 6.79 |
| Aliran Tunai Operasi (OCF TTM) | 145.69 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 183.66 M |
| Pulangan Atas Aset (ROA TTM) | 0.92% |
| Pulangan Atas Ekuiti (ROE TTM) | -1.16% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Menurun |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | Repligen Corporation | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.25 |
|
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 6.41% |
| % Dimiliki oleh Institusi | 105.07% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| United Capital Financial Advisors, Llc | 30 Sep 2025 | 2,755,943 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 200.00 (Barclays, 46.59%) | Beli |
| 200.00 (UBS, 46.59%) | Beli | |
| Median | 200.00 (46.59%) | |
| Rendah | 190.00 (Wells Fargo, 39.26%) | Beli |
| Purata | 196.67 (44.14%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 161.06 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| UBS | 16 Jan 2026 | 200.00 (46.58%) | Beli | 162.02 |
| Barclays | 15 Dec 2025 | 200.00 (46.58%) | Beli | 160.58 |
| Wells Fargo | 15 Dec 2025 | 190.00 (39.26%) | Beli | 160.58 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 06 Jan 2026 | Pengumuman | Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair |
| 18 Dec 2025 | Pengumuman | Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference |
| 16 Dec 2025 | Pengumuman | Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows |
| 26 Nov 2025 | Pengumuman | Repligen Corporation to Present at Evercore Healthcare Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |